Versant Capital Management, Inc Ideaya Biosciences, Inc. Transaction History
Versant Capital Management, Inc
- $637 Million
- Q2 2025
A detailed history of Versant Capital Management, Inc transactions in Ideaya Biosciences, Inc. stock. As of the latest transaction made, Versant Capital Management, Inc holds 2,061 shares of IDYA stock, worth $43,610. This represents 0.01% of its overall portfolio holdings.
Number of Shares
2,061
Previous 566
264.13%
Holding current value
$43,610
Previous $9,000
377.78%
% of portfolio
0.01%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding IDYA
# of Institutions
213Shares Held
80.3MCall Options Held
80.3KPut Options Held
30.5K-
Black Rock Inc. New York, NY6.81MShares$144 Million0.01% of portfolio
-
Janus Henderson Group PLC London, X06.4MShares$135 Million0.06% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.09MShares$108 Million0.0% of portfolio
-
Federated Hermes, Inc. Pittsburgh, PA4.77MShares$101 Million0.18% of portfolio
-
Logos Global Management LP San Francisco, CA3.5MShares$74.1 Million11.17% of portfolio
About IDEAYA Biosciences, Inc.
- Ticker IDYA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 48,067,700
- Market Cap $1.02B
- Description
- IDEAYA Biosciences, Inc., a synthetic lethality-focused precision medicine oncology company, focuses on the discovery and development of targeted therapeutics for patient populations selected using molecular diagnostics. The company's lead product candidates include IDE397, a methionine adenosyltransferase 2a inhibitor that is in Phase I clinica...